Blue Sky Alternatives Access Fund Ltd announces asset exits

Blue Sky Alternatives Access Fund Ltd (ASX:BAF) has given an update on its exits.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Blue Sky Alternatives Access Fund Ltd (ASX: BAF) is the listed investment company (LIC) run by Blue Sky Alternative Investments Ltd (ASX: BLA). It would have been hard to miss all the news recently about how an overseas entity called Glaucus wrote a scathing report about how Blue Sky was allegedly charging a lot of fees and its asset valuations could be too high.

This caused the share prices of both the Blue Sky manager and LIC to fall. The LIC's share price dropped by nearly 25%. However, the LIC recently announced a buyback of its shares and today it has given an update on some of the investments that it is exiting.

  • Gundaline is a large cotton growing development. The LIC made its investment in 2014 and it is now exiting this. Blue Sky estimates that the sale proceeds will be at a slight premium to the carrying value and it achieved an internal rate of return (IRR) of 16%. These are currently estimates.
  • Foundation Early Learning is a childcare operator. The LIC invested in 2014 and has signed the sale of this to an international childcare operator. This sale is estimated to be at a discount of carrying value at 14% to 23% and it is estimated to have generated an IRR of 4% to 7%. Blue Sky blamed this outcome on the substantial de-rating of comparable listed peers.

Foolish takeaway

I think it's a good thing that Blue Sky is being far more transparent about its assets and its goings on now. However, I find it an odd move to sell the Foundation Early Learning asset at a low point. There is every chance that the childcare industry could recover in time.

I was interested in the Blue Sky LIC at one stage, however this whole debacle has made me question whether I would be getting my money's worth.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »